Evidence map›Paper›PMID 27009921›Full record

ReviewBritish journal of haematology2016

Paediatric non-Hodgkin lymphoma - perspectives in translational biology.

Bruce Shiramizu, Lara Mussolin, Wilhelm Woessmann, Wolfram Klapper

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in British journal of haematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bruce ShiramizuJohn A. Burns School of Medicine, Department of Pediatrics, University of Hawaii, Honolulu, USA.
Lara MussolinDepartment of Woman and Child Health, University of Padova, Padova, Italy.
Wilhelm WoessmannDepartment of Paediatric Haematology and Oncology, Justus-Liebig-University, Giessen, Germany.
Wolfram KlapperDepartment of Pathology, Haematopathology Section, University-Hospital Schleswig-Holstein, University of Kiel, Kiel, Germany.

Funding

RESEARCH DESIGN AND BIOSTATISTICS COREU54MD007584 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI MOKUAU, NOREEN, SHIRAMIZU, BRUCE T · 2012 to 2018
$21.1M
NIMHD NIH HHS U54 MD007584
6 · The paper itself

Abstract

Exciting advances have been achieved for infants, children and adolescents diagnosed with, and treated for, non-Hodgkin lymphoma (NHL). In spite of these successes, new frontiers are being paved to improve the prognosis for those who relapse or have resistant disease. This review summarizes some of the novel approaches and ideas in NHL monitoring, diagnosis and treatment as discussed at the 5th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma on October 22nd-24th 2015 in Varese, Italy.

Indexed as

AdolescentChildChild, PreschoolFemaleGenetic TherapyHumansImmunotherapyInfantLymphoma, Non-HodgkinMaleMolecular Diagnostic TechniquesPrognosisSalvage TherapyTranslational Research, Biomedicalchildhood lymphomalymphomanon-Hodgkin lymphoma

Identifiers

PMID27009921
PMCPMC4862896

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.